Long term health outcomes among Returned Peace Corps Volunteers after malaria prophylaxis, 1995-2014. 2017

Kathrine R Tan, and Susan J Henderson, and John Williamson, and Rennie W Ferguson, and Thomas M Wilkinson, and Paul Jung, and Paul M Arguin
Malaria Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: ktan@cdc.gov.

BACKGROUND A primary reason for non-adherence to malaria chemoprophylaxis is fear of latent side effects. We examined latent effects of malaria chemoprophylaxis among Returned Peace Corps Volunteers (RPCVs). METHODS During July 18-September 16, 2016, RPCVs who served during 1995-2014 with an e-mail address in Peace Corps' RPCV database were invited to take an internet-based survey on malaria prophylaxis and medical diagnoses. "Good adherence" meant taking prophylaxis "as prescribed" or "most of the time." Prevalence of diseases diagnosed after Peace Corps service was compared between users and nonusers of each antimalarial using log-binomial regression. RESULTS Of 8931 participants (11% response rate), 5055 (57%) took chemoprophylaxis. Initial chemoprophylaxis was mefloquine 59%, chloroquine 13%, doxycycline 16%, atovaquone-proguanil 4%, and "other" 8%. Sixty percent reported good adherence. Mefloquine users had the best adherence (67% good adherence). Prevalences of most diseases were similar between exposed and unexposed groups. Certain psychiatric diagnoses were slightly more likely among mefloquine users (PR 1.14, 95% CI [1.04-1.25], P = 0.0048). When excluding those with prior psychiatric illness, there were no differences in psychiatric diagnosis rates. CONCLUSIONS Malaria chemoprophylaxis use by Peace Corps Volunteers is safe. Avoiding mefloquine use in those with prior psychiatric illness can reduce psychiatric side effects.

UI MeSH Term Description Entries
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D008297 Male Males
D002727 Proguanil A biguanide compound which metabolizes in the body to form cycloguanil, an anti-malaria agent. Chlorguanid,Chloroguanide,Bigumal,Chloriguane,Chloroguanide Hydrochloride,Paludrin,Paludrine,Proguanil Hydrochloride,Hydrochloride, Chloroguanide,Hydrochloride, Proguanil
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004318 Doxycycline A synthetic tetracycline derivative with similar antimicrobial activity. 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-,Alpha-6-Deoxyoxytetracycline,Atridox,BMY-28689,BU-3839T,Doryx,Doxycycline Calcium,Doxycycline Calcium Salt (1:2),Doxycycline Hemiethanolate,Doxycycline Hyclate,Doxycycline Monohydrate,Doxycycline Monohydrochloride, 6-epimer,Doxycycline Monohydrochloride, Dihydrate,Doxycycline Phosphate (1:1),Doxycycline-Chinoin,Hydramycin,Oracea,Periostat,Vibra-Tabs,Vibramycin,Vibramycin Novum,Vibravenos,Alpha 6 Deoxyoxytetracycline,BMY 28689,BMY28689,BU 3839T,BU3839T,Doxycycline Chinoin,Doxycycline Monohydrochloride, 6 epimer,Vibra Tabs
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Kathrine R Tan, and Susan J Henderson, and John Williamson, and Rennie W Ferguson, and Thomas M Wilkinson, and Paul Jung, and Paul M Arguin
January 2015, Travel medicine and infectious disease,
Kathrine R Tan, and Susan J Henderson, and John Williamson, and Rennie W Ferguson, and Thomas M Wilkinson, and Paul Jung, and Paul M Arguin
March 1997, American journal of public health,
Kathrine R Tan, and Susan J Henderson, and John Williamson, and Rennie W Ferguson, and Thomas M Wilkinson, and Paul Jung, and Paul M Arguin
April 2017, Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention,
Kathrine R Tan, and Susan J Henderson, and John Williamson, and Rennie W Ferguson, and Thomas M Wilkinson, and Paul Jung, and Paul M Arguin
July 1995, AIDS (London, England),
Kathrine R Tan, and Susan J Henderson, and John Williamson, and Rennie W Ferguson, and Thomas M Wilkinson, and Paul Jung, and Paul M Arguin
April 1965, The American journal of nursing,
Kathrine R Tan, and Susan J Henderson, and John Williamson, and Rennie W Ferguson, and Thomas M Wilkinson, and Paul Jung, and Paul M Arguin
January 1990, JAMA,
Kathrine R Tan, and Susan J Henderson, and John Williamson, and Rennie W Ferguson, and Thomas M Wilkinson, and Paul Jung, and Paul M Arguin
June 2009, Community eye health,
Kathrine R Tan, and Susan J Henderson, and John Williamson, and Rennie W Ferguson, and Thomas M Wilkinson, and Paul Jung, and Paul M Arguin
October 1997, Nursing management,
Kathrine R Tan, and Susan J Henderson, and John Williamson, and Rennie W Ferguson, and Thomas M Wilkinson, and Paul Jung, and Paul M Arguin
January 1989, Journal of the American Dietetic Association,
Kathrine R Tan, and Susan J Henderson, and John Williamson, and Rennie W Ferguson, and Thomas M Wilkinson, and Paul Jung, and Paul M Arguin
December 1964, Public health reports (Washington, D.C. : 1896),
Copied contents to your clipboard!